Table 4. The successful treatment rates for single-agent MTX/FA chemotherapy and second-line therapies grouped by the patients FIGO prognostic score.
| FIGO score | First-line MTX/FA | Success rate (%) | Second-line dactinomycin | Success rate (%) | Second-line EMA–CO | Success rate (%) | Third-line EMA–CO | Success rate (%) |
|---|---|---|---|---|---|---|---|---|
| 0 | 53 | 77 | 12 | 92 | — | — | 1 | 100 |
| 1 | 89 | 74 | 15 | 100 | 8 | 100 | — | — |
| 2 | 122 | 67 | 14 | 86 | 26 | 100 | 2 | 100 |
| 3 | 138 | 47 | 28 | 93 | 45 | 100 | 2 | 100 |
| 4 | 93 | 45 | 21 | 100 | 30 | 100 | — | — |
| 5 | 43 | 35 | 5 | 100 | 23 | 100 | — | — |
| 6 | 16 | 31 | 1 | 100 | 10 | 90 | — | — |
| 7 | 3 | 0 | 0 | — | 3 | 100 | — | — |
| Total | 557 |
Abbreviations: EMA–CO=etoposide, MTX, actinomycin D, cyclophosphamide, vincristine; FA=folinic acid; FIGO=Fédération Internationale de Gynécologie et d'Obstétrique; MTX=methotrexate.